We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...

Needham analyst has initiated coverage on Absci Corporation (NASDAQ:ABSI), a drug and target discovery company that harnesses ...

Swayampakula Ramakanth, an analyst from H.C. Wainwright, maintained the Buy rating on AbSci (ABSI – Research Report). The associated price ...

Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, and Owkin, a TechBio that uses agentic AI to unlock complex targets for drug discovery, development, and diagnostics ...

Absci recently received a $20 million PIPE investment from AMD that improves its runway and R&D platform with AI. See why I ...

"In our view, the ability to generate high quality wet-lab data is critical for advancement," analyst says in initiating ...

We recently published a list of Complete List of All AI Companies Under $2 Billion Market Cap. In this article, we are going to take a look at where Absci (NASDAQ:ABSI) stands against other AI ...

AMD will also make a $20 million investment in Absci, structured as a private investment in public equity (PIPE), underscoring the growing demand for innovative AI applications in drug discovery.

The endorsement comes after a recent investor breakfast where Absci's management team discussed the company's competitive edge in the AI-drug discovery sector. Absci's management, including CFO and ...

In this article, we are going to take a look at where Absci Corporation (NASDAQ ... genomic research, drug discovery, clinical processes, and treatment efficacy prediction. According to a 2023 ...

In this article, we are going to take a look at where Absci Corporation (NASDAQ ... witnessed a rapid transformation in early disease detection, genomic research, drug discovery, clinical processes, ...